[vc_row][vc_column][vc_column_text css=”” text_larger=”no”]
| PERIOD ENDED ON |
FINANCIAL RESULTS |
| 14 NOVEMBER 2025 |
Financial Results (Half year ended on 30 Sept. 2025) |
| 29 MAY, 2025 |
Investor Presentation H2 & FY25 |
| 28 MAY, 2025 |
Financial Results |
| 30 SEPTEMBER, 2024 |
Financial Results |
| 01 JUNE, 2024 |
Investor Presentation FY24 |
| 29 MAY, 2024 |
Financial Results |
| 10 JANUARY, 2024 |
Investor Presentation |
| 30 SEPTEMBER, 2023 |
Statement of Deviation |
| 30 SEPTEMBER, 2023 |
Financial Results |
| 31 MARCH, 2023 |
Financial Results |
| 30 SEPTEMBER, 2022 |
Statement of Deviation 30 September 2022 |
| 30 SEPTEMBER, 2022 |
Financial Results – 30 September 2022 |
| 31 MARCH, 2018 |
https://inflameindia.com/downloads/FinRes/FR31032018.pdf |
| 30 SEPTEMBER, 2018 |
https://inflameindia.com/downloads/FinRes/FR30092018.pdf |
| 31 MARCH, 2019 |
https://inflameindia.com/downloads/FinRes/FR31032019.pdf |
| 30 SEPTEMBER, 2019 |
https://inflameindia.com/downloads/FinRes/FR30092019.pdf |
| 31 MARCH, 2020 |
https://inflameindia.com/downloads/FinRes/FR31032020.pdf |
| 30 SEPTEMBER 2020 |
https://inflameindia.com/downloads/FinRes/FR30092020.pdf |
| 31 MARCH 2021 |
https://inflameindia.com/downloads/FinRes/FR31032021.pdf |
| 30 SEPTEMBER 2021 |
Financial Result 30.09.2021
Statement of Deviation 30.09.2021 |
| 31 MARCH 2022 |
Financial Results – 31 March 2022 |
[/vc_column_text][/vc_column][/vc_row]
